Our first Health Technology Assessment and Evidence Synthesis Bulletin of 2025 is out now. It provides a brief summary of our key activities and achievements for the first quarter of the year, including:

• a protocol for a HTA of immunisation of infants and or adults aged 65 and older against respiratory syncytial virus (RSV) in Ireland
• studies being undertaken by CICER regarding asthma, obesity, and a costing tool for infectious disease outbreaks in public acute hospitals
• relocation of the National Immunisation Advisory Committee (NIAC) to HIQA
• a survey on rapid health technology assessment.

Subscribe to receive future issues directly to your inbox at htanews@hiqa.ie.